New research from the Journal of General Internal Medicine shows that these laws are not associated with an increased understanding of the clinical implications of breast density.
While current guidelines recommend genetic testing in women with breast cancer who have relevant family history or clinical criteria, a new study examined whether it makes more sense to test all women with breast cancer.
The US Preventive Services Task Force (UPSTF) recently released an updated recommendation on medications for risk reduction of primary breast cancer and which patients would benefit most from a prescription.
The US Preventive Services Task Force (USPSTF) recently released updated recommendations on risk assessment, genetic counseling, and genetic testing for BRCA-related cancer.
Almost 25% of women with breast cancer have a family history of the disease and, those who do have a higher risk of developing cancer.
BRCA mutation carrying mothers may have different risks depending on whether the mutation is BRCA1 or BRCA2.
Exposure to high levels of DDT is known to increase risk of breast cancer and new research examined whether age of exposure and of diagnosis are connected.
A recent study aimed to quantify the effectiveness of improvements in screening and treatment.
An examination of ACOG’s updated guidelines on breast cancer screening recommendations for the average-risk woman.
While minimally invasive and open surgeries have been found to produce similar survival rates in other early cancers, that might not be the case for early cervical cancer. PLUS: At what age should cervical cancer screening stop? ALSO: How much do genetic variants affect breast cancer risk?